ClinicalTrials.Veeva

Menu

Limits of the Social Benefit Motive Among High-risk Patients: a Field Experiment on Influenza Vaccination Behaviour

S

SB Istanbul Education and Research Hospital

Status

Completed

Conditions

Self-benefit
Social-benefit
Influenza Vaccine
Behavioral Intervention

Treatments

Behavioral: Self-benefit message
Behavioral: Other-benefit message

Study type

Interventional

Funder types

Other

Identifiers

NCT04230343
855 - 21/10/2016

Details and patient eligibility

About

Influenza vaccine uptake remains low worldwide, inflicting substantial costs to public health and health systems. Messages promoting social welfare have been shown to increase vaccination intentions, and it has been recommended that health professionals communicate the socially beneficial aspects of vaccination. This study aims to provide the first test whether this prosocial vaccination hypothesis applies to the actual vaccination behaviour of high-risk patients by comparing the effects of two motivational messages for promoting vaccination at a tertiary care public hospital in Istanbul, Turkey.

Enrollment

244 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients hospitalized at medical departments of the hospital who are on the day of discharge

Exclusion criteria

  • Egg ellergy
  • Previous allergic reaction to influenza vaccine
  • Pregnancy
  • Cognitive disability

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

244 participants in 2 patient groups

Self-benefit arm
Experimental group
Treatment:
Behavioral: Self-benefit message
Social-benefit arm
Active Comparator group
Treatment:
Behavioral: Other-benefit message

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems